UroGen Pharma Ltd.

NASDAQ: URGN · Real-Time Price · USD
19.74
-0.34 (-1.69%)
At close: Aug 15, 2025, 3:59 PM
19.50
-1.22%
After-hours: Aug 15, 2025, 06:59 PM EDT

UroGen Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-49.94M -43.84M -37.51M -23.67M -33.4M -32.29M -26.02M -21.88M -24.14M -30.21M -28.87M -25.83M -26.69M -28.39M -28.45M -30.21M -26.22M -25.93M
Depreciation & Amortization
596K 497K 306K 266K 263K 351K 424K 415K 431K 435K 450K 435K 476K 456K 451K 452K 442K 428K
Stock-Based Compensation
2.73M 3.07M 3.3M 3.49M 3.56M 2.76M 2.61M 2.22M 2.22M 2.29M 2.37M 2.44M 2.82M 2.95M 5.36M 5.51M 6.05M 6.2M
Other Working Capital
4.13M -7.78M 6.88M 483.31K 427K -5.35M 7.37M -1.38M 1.32M -5.06M 749K -1.36M -1.16M -3.47M 430K -2.44M 2.24M -7.79M
Other Non-Cash Items
1.53M 839K 4.79M 1.38M 3.27M 1.46M 7.59M 222K 355K 2.92M 3.52M 4M 4.29M 4.33M -8.85M 5.99M 2.08M -400K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -4.25M 2.77M 2.8M n/a n/a n/a n/a n/a 14.98M 162K -10K 191K
Change in Working Capital
5.25M -2.59M 15.49M -9.12M 2.57M -4.01M 6.58M -1.05M -1.95M -1.24M 784K 1.35M -5.09M -3.34M -3.56M -385K -1.28M -7.88M
Operating Cash Flow
-39.83M -42.02M -13.62M -27.66M -23.75M -31.73M -13.06M -17.3M -20.27M -25.81M -21.75M -17.61M -24.2M -24M -20.07M -18.48M -18.95M -27.4M
Capital Expenditures
-141K -44K -115K -96K -84K n/a -53.54K -100K -15K -23K -13K -153K -63K -25K -202K -194K -69K -287K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 11.29M -501K -4.12M n/a -23.55M 35.34M n/a n/a n/a n/a n/a n/a
Purchase of Investments
-1.79M -66.35M -9.23M -118.79M n/a n/a -14.18M -10.83M 388.5K -24.18M 429.44K -63.01M n/a n/a -304K -9.94M -41.66M n/a
Sales Maturities Of Investments
30.34M 40.43M 69.97M 12.14M 12.08M 13.52M 3.25M 11.33M 3.73M 30.47M 23.12M 27.67M -88K 13.62M 9.63M 20.79M 10.98M 15.31M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a -11.65M 501K 3.73M n/a 23.12M -35.34M -88K 13.62M 9.33M 10.85M -30.67M 15.31M
Investing Cash Flow
28.41M -25.96M 60.62M -106.75M 12M 13.52M -11.34M 401K 3.72M 6.27M 23.11M -35.49M -151K 13.6M 9.13M 10.66M -30.74M 15.02M
Debt Repayment
n/a n/a -24.39M 24.39M n/a n/a n/a n/a n/a n/a 24.99M n/a -38K 70.83M n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -15K -52K n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-1.59K n/a 175.63M 210.07K 18.78M n/a 417.96K 48.72M 143K 671K 378K 1.1M -39K -89K -32K -168K 72.52M 4K
Financial Cash Flow
296K 34K 71K 39.61M 100.28M 54.66M 40K 116.08M 143K 671K 25.37M 1.1M -77K 70.74M -32K -168K 72.52M 4K
Net Cash Flow
-11.12M -67.95M 47.07M -94.81M 88.53M 36.44M -24.3M 99.18M -16.41M -18.87M 26.72M -52M -24.43M 60.34M -10.98M -7.98M 22.83M -12.37M
Free Cash Flow
-39.97M -42.07M -13.73M -27.76M -23.83M -31.73M -13.11M -17.4M -20.29M -25.83M -21.77M -17.77M -24.26M -24.02M -20.27M -18.67M -19.01M -27.69M